The diagnostics and treatment of dishormonal mammal hyperplasia in uterine myoma patients

Cover Page


Cite item

Full Text

Abstract

In gynecologic patients with internal genitalia diseases (endometriosis, uterine myoma) the frequency of mammal hyperplasia makes up to 60- 95%. The research aim was to study the effectiveness of conservative therapy with gestagens (norcolut, orgametril) application in benign hyperplastic mammal processes management in patients with uterine myomas. The effectiveness of gestagens application in patients with uterine myomas with coexisting dyshormonal mammal hyperplasia is proved.

About the authors

Ju. V. Tzvelev

Russian Military Medical Academy

Author for correspondence.
Email: info@eco-vector.com
Russian Federation, St. Petersburg

A. B. Ilyin

Russian Military Medical Academy

Email: info@eco-vector.com
Russian Federation, St. Petersburg

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 1999 Eсо-Vector



Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).